National Institute On Drug Abuse (nida)

This study tests whether tirzepatide, a drug used for diabetes, can help people with moderate to severe cannabis use disorder cut back or stop using cannabis. One hundred adults aged 18 to 70 will receive either the drug or a placebo, and researchers will track how many days per …

This early-stage study is the first to test MG001, a compound from the kratom plant, in people. About 32 healthy adults who have used opioids recently will receive a single dose of MG001 or a placebo. Researchers will monitor for side effects and measure how the drug moves throug…

This early-stage study tests a new oral drug called VK4-116 in 48 healthy volunteers to see if it is safe and how the body handles it. Participants receive either a single dose of the drug or a placebo, and researchers monitor side effects and drug levels in the blood. The goal i…

This early-stage study tests a new type of brain stimulation called high-density theta burst stimulation (hdTBS) in 35 healthy adults aged 22 to 60. The goal is to check if it is safe and to see how it affects brain activity compared to standard stimulation. Participants will hav…

This study aims to understand how different parts of the brain control our sense of smell and guide our behavior. Healthy adults aged 18 to 45 will undergo tasks involving odors, pictures, and sounds while researchers use ultrasound and brain scans to measure brain activity. The …